Efficacy of Bacteriophages in Propionibacterium acnes-Induced Inflammation in Mice

Min Ji Kim1, Dong Hyuk Eun1, Seok Min Kim1

  • 1Department of Dermatology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea.

Annals of Dermatology
|April 29, 2021
PubMed
Abstract

Insights

Bacteriophages show promise as an alternative acne therapy. In a mouse model, bacteriophage treatment significantly reduced inflammatory nodule size and severity caused by Propionibacterium acnes.

Area of Science:

  • Microbiology
  • Dermatology
  • Therapeutics

Background:

  • Bacteriophages are emerging as potential antimicrobial agents for infectious diseases.
  • They offer a possible alternative to traditional acne treatments, especially for resistant cases.

Purpose of the Study:

  • To evaluate the efficacy of bacteriophages in an acne mouse model.
  • To assess the impact of bacteriophages on Propionibacterium acnes-induced inflammatory lesions.

Main Methods:

  • An acne mouse model was established using Propionibacterium acnes injections.
  • Mice were divided into control, P. acnes-only, and P. acnes plus bacteriophage groups.
  • Clinical, pathological, and immunohistochemical analyses were conducted.

Main Results:

  • Bacteriophage treatment (Group C) resulted in the greatest reduction in inflammatory nodule size.
  • Histopathology revealed decreased epidermal thickness and fewer microcomedone-like cysts in bacteriophage-treated groups.
  • Key inflammatory markers and immune cell infiltration showed similar expression across all groups.

Conclusions:

  • Bacteriophages demonstrate potential as an alternative therapeutic strategy for acne.
  • Further research is necessary to validate these findings for human application.